Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Jan;232(1):233-43.
doi: 10.1007/s00213-014-3652-9. Epub 2014 Jun 29.

A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers

Lorenzo Leggio  1 , William H Zywiak, Steven M Edwards, Jennifer W Tidey, Robert M Swift, George A Kenna
Affiliations
Randomized Controlled Trial

A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers

Lorenzo Leggio et al. Psychopharmacology (Berl). 2015 Jan.

Erratum in

Abstract

Rationale: There is presently no approved single treatment for dual alcohol and nicotine dependencies.

Objective: This pilot study investigated baclofen effects in alcoholic smokers.

Methods: This was a preliminary double-blind placebo-controlled randomized clinical study with 30 alcoholic smokers randomized to baclofen at 80 mg/day or placebo. A subgroup (n=18) participated in an alcohol cue-reactivity experiment.

Results: Baclofen, compared with placebo, significantly decreased the percent days of abstinence from alcohol-tobacco co-use (p=0.004). Alcohol dependence severity moderated baclofen effects, with the higher severity group having the greater baclofen response (p<0.001). Although the percent days of alcohol-tobacco co-use declined in both groups, this decline was greater after placebo than baclofen (p<0.001). Secondary analyses on alcohol or tobacco use alone suggested that the increase in percent days of co-abstinence was driven by the medication differences on heavy drinking days and on percent days smoking. In the cue-reactivity substudy, baclofen slightly decreased alcohol urge (p=0.058) and significantly reduced salivation (p=0.001), but these effects were not related to cue type.

Conclusions: This study provides preliminary evidence suggesting a possible role of baclofen in the treatment of alcoholic smokers. However, the mixed results and the small sample require larger confirmatory studies.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Dr. Swift has received travel and honorarium from D&A Pharma, and consultant fees from CT Laboratories. Dr. Kenna has received consultant fees from CT Laboratories. The other authors report no biomedical financial interests or potential conflicts of interest.

Figures

Fig. 1
Fig. 1
Effects of baclofen vs. placebo on the percent days of abstinence from alcohol-tobacco co-use (a), tobacco (b), and alcohol (c)
Fig. 2
Fig. 2
Effects of baclofen vs. placebo on the percent days of alcohol-tobacco co-use
Fig. 3
Fig. 3
Effects of baclofen vs. placebo on salivation following water vs. alcohol cues
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G. Ability of baclofen in reducing alcohol craving and intake: II—preliminary clinical evidence. Alcohol Clin Exp Res. 2000;24:67–71. - PubMed
    1. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, Gasbarrini G. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol. 2002a;37:504–508. - PubMed
    1. Addolorato G, Caputo F, Capristo E, Janiri L, Bernardi M, Agabio R, Colombo G, Gessa GL, Gasbarrini G. Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med. 2002b;112:226–229. - PubMed
    1. Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med. 2006;119(276):e213–e278. - PubMed
    1. Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, Abenavoli L, D’Angelo C, Caputo F, Zambon A, Haber PS, Gasbarrini G. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet. 2007;370:1915–1922. - PubMed

Publication types